Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2021 Filed Mar 4, 2021 00:08 UTC |
Berge Terence MVP-Corporate Controller
|
Exercise / conversionCommon Stock | 2,550 | $97.69 | $249,109.50 |
DisclosureSEC source: 0001127602-21-009281 · form4.xml · nonDerivative · entry 9 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:08 UTC |
Berge Terence MVP-Corporate Controller
|
SaleCommon Stock | 5,400 | $122.50 | $661,500.00 |
DisclosureSEC source: 0001127602-21-009281 · form4.xml · nonDerivative · entry 8 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,004 Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:08 UTC |
Berge Terence MVP-Corporate Controller
|
Exercise / conversionCommon Stock | 5,400 | $78.76 | $425,304.00 |
DisclosureSEC source: 0001127602-21-009281 · form4.xml · nonDerivative · entry 7 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,404 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:08 UTC |
Berge Terence MVP-Corporate Controller
|
SaleCommon Stock | 2,700 | $122.50 | $330,750.00 |
DisclosureSEC source: 0001127602-21-009281 · form4.xml · nonDerivative · entry 6 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,004 Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:08 UTC |
Berge Terence MVP-Corporate Controller
|
Exercise / conversionCommon Stock | 2,700 | $59.96 | $161,892.00 |
DisclosureSEC source: 0001127602-21-009281 · form4.xml · nonDerivative · entry 5 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:08 UTC |
Berge Terence MVP-Corporate Controller
|
SaleCommon Stock | 2,800 | $122.53 | $343,074.76 |
DisclosureSEC source: 0001127602-21-009281 · form4.xml · nonDerivative · entry 4 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,004 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.50 to $122.62. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:08 UTC |
Berge Terence MVP-Corporate Controller
|
Exercise / conversionCommon Stock | 2,800 | $41.93 | $117,404.00 |
DisclosureSEC source: 0001127602-21-009281 · form4.xml · nonDerivative · entry 3 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,804 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:08 UTC |
Berge Terence MVP-Corporate Controller
|
SaleCommon Stock | 3,860 | $122.77 | $473,902.62 |
DisclosureSEC source: 0001127602-21-009281 · form4.xml · nonDerivative · entry 2 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,004 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.66 to $122.99. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:08 UTC |
Berge Terence MVP-Corporate Controller
|
Exercise / conversionCommon Stock | 3,860 | $39.87 | $153,898.20 |
DisclosureSEC source: 0001127602-21-009281 · form4.xml · nonDerivative · entry 1 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,864 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:52 UTC |
TRYNISKI MARK EDirector
|
SaleCommon Stock | 3,400 | $122.23 | $415,582.00 |
DisclosureSEC source: 0001127602-21-007405 · form4.xml · nonDerivative · entry 2 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,889 Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:52 UTC |
TRYNISKI MARK EDirector
|
SaleCommon Stock | 90 | $122.05 | $10,984.50 |
DisclosureSEC source: 0001127602-21-007405 · form4.xml · nonDerivative · entry 1 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,289 Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:32 UTC |
Hartman Curt RDirector · President, CEO and Chair
|
SaleCommon Stock | 3,100 | $120.68 | $374,108.00 |
DisclosureSEC source: 0001127602-21-006762 · form4.xml · nonDerivative · entry 2 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,857 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.10 to $121.00. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:32 UTC |
Hartman Curt RDirector · President, CEO and Chair
|
SaleCommon Stock | 11,900 | $119.73 | $1,424,787.00 |
DisclosureSEC source: 0001127602-21-006762 · form4.xml · nonDerivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,957 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.00 to $119.80. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 18:05 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 7,195 | $0.00 Strike: $41.06 | $0.00 |
DisclosureSEC source: 0001127602-21-006424 · form4.xml · derivative · entry 20 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,195 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 18:05 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 1,000 | $0.00 Strike: $55.70 | $0.00 |
DisclosureSEC source: 0001127602-21-006424 · form4.xml · derivative · entry 19 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2025-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 18:05 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 1,000 | $0.00 Strike: $39.64 | $0.00 |
DisclosureSEC source: 0001127602-21-006424 · form4.xml · derivative · entry 18 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2024-09-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting upon completion of the term of service. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 18:05 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 1,000 | $0.00 Strike: $32.93 | $0.00 |
DisclosureSEC source: 0001127602-21-006424 · form4.xml · derivative · entry 17 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2023-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 18:05 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 1,000 | $0.00 Strike: $26.09 | $0.00 |
DisclosureSEC source: 0001127602-21-006424 · form4.xml · derivative · entry 16 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2022-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 18:05 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 1,000 | $0.00 Strike: $27.63 | $0.00 |
DisclosureSEC source: 0001127602-21-006424 · form4.xml · derivative · entry 15 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2021-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 18:05 UTC |
TRYNISKI MARK EDirector
|
SaleCommon Stock | 2,545 | $121.31 | $308,733.95 |
DisclosureSEC source: 0001127602-21-006424 · form4.xml · nonDerivative · entry 14 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,379 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.21 to $122.11. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 18:05 UTC |
TRYNISKI MARK EDirector
|
SaleCommon Stock | 2,230 | $120.88 | $269,562.40 |
DisclosureSEC source: 0001127602-21-006424 · form4.xml · nonDerivative · entry 13 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,924 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.56 to $121.15. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 18:05 UTC |
TRYNISKI MARK EDirector
|
Tax withholdingCommon Stock | 2,420 | $122.10 | $295,482.00 |
DisclosureSEC source: 0001127602-21-006424 · form4.xml · nonDerivative · entry 12 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,154 Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 18:05 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionCommon Stock | 7,195 | $41.06 | $295,426.70 |
DisclosureSEC source: 0001127602-21-006424 · form4.xml · nonDerivative · entry 11 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,574 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 18:05 UTC |
TRYNISKI MARK EDirector
|
Tax withholdingCommon Stock | 462 | $120.69 | $55,758.78 |
DisclosureSEC source: 0001127602-21-006424 · form4.xml · nonDerivative · entry 10 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,379 Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 18:05 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionCommon Stock | 1,000 | $53.83 | $53,830.00 |
DisclosureSEC source: 0001127602-21-006424 · form4.xml · nonDerivative · entry 9 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,841 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 18:05 UTC |
TRYNISKI MARK EDirector
|
Tax withholdingCommon Stock | 329 | $120.69 | $39,707.01 |
DisclosureSEC source: 0001127602-21-006424 · form4.xml · nonDerivative · entry 8 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,841 Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 18:05 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionCommon Stock | 1,000 | $39.64 | $39,640.00 |
DisclosureSEC source: 0001127602-21-006424 · form4.xml · nonDerivative · entry 7 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,170 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 18:05 UTC |
TRYNISKI MARK EDirector
|
Tax withholdingCommon Stock | 273 | $120.69 | $32,948.37 |
DisclosureSEC source: 0001127602-21-006424 · form4.xml · nonDerivative · entry 6 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,170 Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 18:05 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionCommon Stock | 1,000 | $32.93 | $32,930.00 |
DisclosureSEC source: 0001127602-21-006424 · form4.xml · nonDerivative · entry 5 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,443 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 18:05 UTC |
TRYNISKI MARK EDirector
|
Tax withholdingCommon Stock | 217 | $120.69 | $26,189.73 |
DisclosureSEC source: 0001127602-21-006424 · form4.xml · nonDerivative · entry 4 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,443 Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 18:05 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionCommon Stock | 1,000 | $26.09 | $26,090.00 |
DisclosureSEC source: 0001127602-21-006424 · form4.xml · nonDerivative · entry 3 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,660 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 18:05 UTC |
TRYNISKI MARK EDirector
|
Tax withholdingCommon Stock | 229 | $120.69 | $27,638.01 |
DisclosureSEC source: 0001127602-21-006424 · form4.xml · nonDerivative · entry 2 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,660 Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 18:05 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionCommon Stock | 1,000 | $27.63 | $27,630.00 |
DisclosureSEC source: 0001127602-21-006424 · form4.xml · nonDerivative · entry 1 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,889 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 21:25 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 2,000 | $0.00 Strike: $59.96 | $0.00 |
DisclosureSEC source: 0001127602-21-004175 · form4.xml · derivative · entry 6 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,500 Underlying: Common Stock · 2,000 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 21:25 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 3,000 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-21-004175 · form4.xml · derivative · entry 5 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 3,000 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 21:25 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
SaleCommon Stock | 2,000 | $116.11 | $232,222.00 |
DisclosureSEC source: 0001127602-21-004175 · form4.xml · nonDerivative · entry 4 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,881 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.00 to $116.37. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 21:25 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
Exercise / conversionCommon Stock | 2,000 | $59.96 | $119,920.00 |
DisclosureSEC source: 0001127602-21-004175 · form4.xml · nonDerivative · entry 3 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,881 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 21:25 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
SaleCommon Stock | 3,000 | $116.09 | $348,260.70 |
DisclosureSEC source: 0001127602-21-004175 · form4.xml · nonDerivative · entry 2 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,881 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.00 to $116.44. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 21:25 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
Exercise / conversionCommon Stock | 3,000 | $41.93 | $125,790.00 |
DisclosureSEC source: 0001127602-21-004175 · form4.xml · nonDerivative · entry 1 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,881 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 01:54 UTC |
Cohen Heather LEVP CORP HR
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 5,000 | $0.00 Strike: $27.63 | $0.00 |
DisclosureSEC source: 0001127602-21-002192 · form4.xml · derivative · entry 3 Cohen Heather L · CIK 0001436649 · EVP CORP HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2021-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 01:54 UTC |
Cohen Heather LEVP CORP HR
|
Tax withholdingCommon Stock | 2,533 | $116.98 | $296,310.34 |
DisclosureSEC source: 0001127602-21-002192 · form4.xml · nonDerivative · entry 2 Cohen Heather L · CIK 0001436649 · EVP CORP HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,265 Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 01:54 UTC |
Cohen Heather LEVP CORP HR
|
Exercise / conversionCommon Stock | 5,000 | $27.63 | $138,150.00 |
DisclosureSEC source: 0001127602-21-002192 · form4.xml · nonDerivative · entry 1 Cohen Heather L · CIK 0001436649 · EVP CORP HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,798 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise reported above was pursuant to a previously adopted 10b5-1 Plan. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:16 UTC |
Garner Todd WExecutive Vice President & CFO
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 2,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-000980 · form4.xml · derivative · entry 3 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2028-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.001 per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (25%) over a four year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:16 UTC |
Garner Todd WExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 980 | $111.35 | $109,123.00 |
DisclosureSEC source: 0001127602-21-000980 · form4.xml · nonDerivative · entry 2 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,549 Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:16 UTC |
Garner Todd WExecutive Vice President & CFO
|
Exercise / conversionCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-000980 · form4.xml · nonDerivative · entry 1 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,529 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2021 Filed Jan 8, 2021 22:36 UTC Amendment |
Garner Todd WExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 650 | $111.35 | $72,377.50 |
DisclosureSEC source: 0001127602-21-001294 · form4a.xml · nonDerivative · entry 1 Garner Todd W. · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,879 F1 · shares: Initial Form 4 indicated incorrect shares withheld due to calculation error by brokerage firm. Read SEC document |
| December 31, 2020 Filed Feb 5, 2021 21:23 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Other401 (K) Plan | 151.337 | $112.00 | $16,949.74 |
DisclosureSEC source: 0001127602-21-004173 · form5.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (K) Plan Disclosed balance after: 1,084.622 F1 · date: As of December 31, 2020. F2 · balance_after: No change in holdings other than as a result of a change in the shares of stock in the 401(K) Conmed fund. Read SEC document |
| December 31, 2020 Filed Feb 5, 2021 21:19 UTC |
Cohen Heather LEVP CORP HR
|
Other401 (K) Plan | 52.368 | $112.00 | $5,865.22 |
DisclosureSEC source: 0001127602-21-004167 · form5.xml · nonDerivative · entry 1 Cohen Heather L · CIK 0001436649 · EVP CORP HR 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (K) Plan Disclosed balance after: 4,904.78 F1 · date: As of 12/31/2020. F2 · balance_after: No change in holdings other than as a result of a change in the shares of stock in the 401(K) Conmed fund. Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 20:00 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 6,000 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-20-031505 · form4.xml · derivative · entry 3 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,700 Underlying: Common Stock · 6,000 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 20:00 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
SaleCommon Stock | 6,000 | $108.70 | $652,200.00 |
DisclosureSEC source: 0001127602-20-031505 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.66 to $108.76. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.